万东CGO-3000血管造影介入治疗系统故障维修

万东血管造影介入治疗系统适用于各大中型医院,用于血管造影检查和介入治疗。该系统主要包括三个主要的子系统,一是高频X射线发生装置,二是数字图像系统,三是C型臂导管床。下面简要介绍一下数字图像采集处理系统几例常见故障及解决办法。

首台国产磁共振影像导航介入治疗系统“落户”协和

7月24日电在以开放式磁共振成像设备为基础的介入治疗平台上，患者的病变部位被毫厘不差地放大在液晶显示屏上，医生可以通过显示屏进行各种手术操作。随着具有自主知识产权、处于世界领先地位的首台国产磁共振影像导航介入治疗系统正式落户北京协和医院，这种科幻般的诊疗场景正在成为现实。

磁共振导航介入治疗系统

磁共振成像与介入放射学的结合，形成了“磁共振导航介入”这项全新的技术，该技术综合了两者的优势，成为当前最具活力、最有前景的诊疗手段之一.

具有自主科技创新的中国首台“MRI图像导航介入治疗系统”落户北京协和医院

2006年7月23日在北京协和医院举行了“低场磁共振新技术研讨会暨北京协和医院新奥博为磁共振成像系统开机仪式”.新奥博为研发的国内首台“MRI图像导航介入治疗系统”正式落户北京协和医院.

Interventional and synthetic therapy of advanced hepatocellular carcinoma

OBJECTIVE: To evaluate the clinical efficacy of interventional therapy in the treatment of hepatocellular carcinoma (HCC). METHODS: Thirty-three patients with HCC were synthetically treated by systematic measures. Among them, percutaneous port-catheter system (PCS) implantation via the femoral artery was performed in 21 cases. Patients with haemorrhage were treated with prothrombin complex concentrate and fibroraas, and patients with hepatic encephalopathy by branched-chain amino acids and arginine. RESULTS: All indwelling catheters of PCS were patent and no catheter tip dislocations were observed. Of 33 patients with advanced HCC, the mean survival rate was 20.1 months and 12 (36%) patients survived more than 2 years. CONCLUSION: Patients with advanced HCC were treated by synthetic measures. Survival was prolonged, quality of life was improved significantly, and the effectiveness of interventional therapy was further improved.